Directory
>
Ian Schnadig
Ian Schnadig
Member, PC Board of Directors | Compass Oncology
Portland, Oregon, United States
Ian Schnadig
Summary
Dr. Ian Schnadig is a highly accomplished physician with a focus on oncology and a proven track record in clinical research and management. Currently serving as the Chief Medical Officer and a Board Member at Compass Oncology, he has dedicated his career to advancing treatment options for patients with bladder, kidney, and prostate cancers. His extensive experience includes leadership roles in various medical organizations, where he has contributed significantly to clinical trials and healthcare management. Dr. Schnadig is also recognized for his research publications in prestigious medical journals, underscoring his commitment to improving patient outcomes through evidence-based practices. With a background in internal medicine and hematology, he combines clinical expertise with a passion for medical education and mentorship. His leadership in the Genitourinary Cancer Program at The US Oncology Network highlights his dedication to collaborative care and innovation in oncology. Dr. Schnadig's contributions extend beyond the clinic, as he actively participates in committees focused on pharmacy and therapeutics, shaping the future of cancer treatment protocols.
Ian Schnadig
Work Experience
Member, PC Board of Directors at
Compass Oncology
May 2022 - Present
Chief Medical Officer at
Compass Oncology
November 2021 - Present
Active Member, Genitourinary Cancer Program at
The US Oncology Network
August 2010 - Present
Physician, Hematology & Medical Oncology at
Compass Oncology
July 2010 - Present
Site Principle Investigator, Eastern Cooperative Oncology Group (ECOG) Trials at
Legacy Health
September 2011 - May 2022
Chairman, Pharmacy and Therapeutics at
Compass Oncology
May 2013 - May 2022
GU Chair, Pathways Task Force, Pharmacy and Therapeutics Committee at
McKesson
February 2012 - February 2021
Board Member at
Compass Oncology
May 2013 - May 2018
Active Member, Developmental Therapeutics Program at
The US Oncology Network
September 2010 - September 2017
Executive Committee, Pharmacy and Therapeutics Executive Committee at
McKesson Specialty Health
May 2013 - May 2015
Medical Director, Health Informatics at
McKesson Specialty Health
January 2011 - July 2014
Network PI, USON 10231 - PX866 in Combination with Docetaxel in Advanced NSCLC and SCCHN at
Us Oncology
August 2011 - May 2013
Physician, Hematology & Medical Oncology at
New Mexico Cancer Center- New Mexico Oncology Hematology Consultants, LTD
September 2008 - April 2010
Fellow, Hematology & Oncology at
Ohsu
January 2005 - January 2008
Resident, Internal Medicine at
Ohsu
January 2002 - January 2005
Marketing Associate at
Leasepartners
January 1992 - January 1993
Ian Schnadig
Education
Rush Medical College of Rush University Medical Center, M.D.
January 1998 - January 2002
January 1986 - January 1991
Frequently Asked Questions about Ian Schnadig
What is Ian Schnadig email address?
Ian Schnadig's primary email address is ************@compassoncology.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Ian Schnadig work for?
Ian Schnadig is a Member, PC Board of Directors at Compass Oncology, a company specializing in General Medical & Surgical Hospitals.
Where Ian Schnadig graduated from?
Ian Schnadig holds a degree in from Rush Medical College of Rush University Medical Center.
How can I directly contact Ian Schnadig?
To contact Ian Schnadig directly, you can use the email address ************@compassoncology.com. Complete contact information is available upon registration with Muraena.
Who is Ian Schnadig?
Dr. Ian Schnadig is a highly accomplished physician with a focus on oncology and a proven track record in clinical research and management. Currently serving as the Chief Medical Officer and a Board Member at Compass Oncology, he has dedicated his career to advancing treatment options for patients with bladder, kidney, and prostate cancers. His extensive experience includes leadership roles in various medical organizations, where he has contributed significantly to clinical trials and healthcare management. Dr. Schnadig is also recognized for his research publications in prestigious medical journals, underscoring his commitment to improving patient outcomes through evidence-based practices. With a background in internal medicine and hematology, he combines clinical expertise with a passion for medical education and mentorship. His leadership in the Genitourinary Cancer Program at The US Oncology Network highlights his dedication to collaborative care and innovation in oncology. Dr. Schnadig's contributions extend beyond the clinic, as he actively participates in committees focused on pharmacy and therapeutics, shaping the future of cancer treatment protocols.
Ian`s contact details
************@compassoncology.com
************@usoncology.com
Colleagues
Executive Director
State Controller
Board Member
Chief Medical Physicist
Practice President